Kenvue Inc. $KVUE Shares Purchased by Wealthfront Advisers LLC

Wealthfront Advisers LLC increased its stake in shares of Kenvue Inc. (NYSE:KVUE) by 117.8% in the 4th quarter, HoldingsChannel reports. The firm owned 306,713 shares of the company’s stock after purchasing an additional 165,868 shares during the period. Wealthfront Advisers LLC’s holdings in Kenvue were worth $5,291,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of KVUE. Van ECK Associates Corp grew its stake in Kenvue by 101.3% during the 3rd quarter. Van ECK Associates Corp now owns 18,361,581 shares of the company’s stock worth $298,008,000 after purchasing an additional 9,240,434 shares in the last quarter. American Century Companies Inc. grew its holdings in Kenvue by 22.4% during the 3rd quarter. American Century Companies Inc. now owns 37,046,660 shares of the company’s stock worth $601,267,000 after acquiring an additional 6,781,640 shares in the last quarter. Mondrian Investment Partners LTD acquired a new position in Kenvue during the 3rd quarter worth approximately $79,269,000. Alliancebernstein L.P. grew its holdings in Kenvue by 115.9% during the 2nd quarter. Alliancebernstein L.P. now owns 6,438,473 shares of the company’s stock worth $134,757,000 after acquiring an additional 3,456,204 shares in the last quarter. Finally, Amundi grew its holdings in Kenvue by 21.6% during the 3rd quarter. Amundi now owns 17,645,761 shares of the company’s stock worth $277,012,000 after acquiring an additional 3,135,871 shares in the last quarter. 97.64% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts have commented on KVUE shares. Weiss Ratings reiterated a “hold (c-)” rating on shares of Kenvue in a report on Wednesday, April 8th. Citigroup lowered their price target on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a report on Wednesday, April 15th. Argus raised Kenvue to a “hold” rating in a research report on Friday, March 6th. Canaccord Genuity Group upped their price objective on Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a research report on Wednesday, February 18th. Finally, Jefferies Financial Group cut Kenvue from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $23.00 to $18.00 in a research report on Friday, January 30th. Three analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $19.33.

Kenvue Stock Up 2.0%

Shares of NYSE KVUE opened at $17.58 on Friday. The stock has a market cap of $33.74 billion, a PE ratio of 22.82, a price-to-earnings-growth ratio of 3.91 and a beta of 0.61. The company has a quick ratio of 0.68, a current ratio of 0.96 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 52-week low of $14.02 and a 52-week high of $25.17. The business has a 50-day moving average price of $17.72 and a 200 day moving average price of $17.17.

Kenvue (NYSE:KVUE) last announced its earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.22 by $0.05. The firm had revenue of $3.78 billion during the quarter, compared to analysts’ expectations of $3.68 billion. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.The business’s revenue was up 3.2% on a year-over-year basis. During the same period in the prior year, the firm earned $0.26 EPS. Equities research analysts forecast that Kenvue Inc. will post 1.1 earnings per share for the current year.

Kenvue Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th will be paid a dividend of $0.2075 per share. The ex-dividend date is Wednesday, May 13th. This represents a $0.83 dividend on an annualized basis and a yield of 4.7%. Kenvue’s dividend payout ratio is currently 107.79%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over?the?counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.